IRhythm Technologies Is Maintained at Outperform by Oppenheimer

Dow JonesJan 8 09:10 ET · Ratings

Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $120

Moomoo NewsJan 8 08:34 ET · Ratings

Express News | IRhythm Technologies Inc : Oppenheimer Raises Target Price to $120 From $105

ReutersJan 8 08:18 ET

The Zacks Analyst Blog Highlights Tempus AI, IRhythm Technologies and SOPHiA GENETICS

Zacks Jan 8 08:05 ET

Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)

TipRanksJan 8 07:36 ET · Ratings

Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry

Yahoo FinanceJan 6 06:45 ET